Patent Yard Sign in
Expired Canadian patentCanada

Percutaneous absorption enhancers, compositions containing same and method of use

CA 1313619 C · Owner: Samour, Carlos M. · Inventors: Daskalakis, Stefanos; Samour, Carlos M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Novel 1,3-dioxacycloalkanes are provided along with new 1,3-dioxacycloalkane compositions which are useful in enhancing the absorption of therapeutic agents through the skin of humans and animals, The method for enhancing skin penetration of therapeutic agents using 1,3-dioxacycloalkanes is also described. The preferred compounds are 1,3-dioxacycloalkanes (1,3-dioxacycloalkanes) and 1,3-dioxanes (1,3-dioxacyclohexanes). The preferred compounds have the formula:, wherein R R0, R1, R2, R3, R4, R5, and R6 are each independently selected from hydrogen and C1 and C18 aliphatic groups preferably, alkyl, alkenyl, halo, hydroxy carboxy, carboxamide, and carboalkoxy, substituted forms thereof with …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted February 16, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 16, 2010.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 16, 1987
GrantedFebruary 16, 1993
Term endedFebruary 16, 2010
Patent numberCA 1313619 C
Classification (IPC)A61K47/22 +2 more

Timeline

Timeline From CIPO dates

19881991199419972000200320062009Application filedNov 16, 1987Patent grantedFeb 16, 1993Term endedFeb 16, 2010

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.